Latest News
SuperMaker AI Launches Free AI Video Platform That Actually Works
SHERIDAN, Wyo., May 30, 2025 /PRNewswire/ -- Here's something cool. SuperMaker
AI
2025-05-30 22:30
3377
dancemoon Reinvents Itself with Its First Bathroom Essential: the JustHang Squeegee
NEW YORK, May 30, 2025 /PRNewswire/ -- dancemoon, the trailblazer in home cleaning innovation,is excited to announce the launch of its first bathroom essential product: the dancemoon JustHang Squeegee. The product will be available for pre-order in the US startingMay 30 on the brand's official w...
2025-05-30 22:00
3578
Fosi Audio Debuts 1st MemberFest -- Building a Unique Global HiFi Community
SHENZHEN, China, May 30, 2025 /PRNewswire/ -- Fosi Audio, a brand committed to redefining high-fidelity sound with unmatched value and user-centered innovation, has officially launched its inaugural MemberFest, running fromMay 27 to June 8 (PST). The event celebrates the brand's growing global co...
2025-05-30 22:00
3842
Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)
SHANGHAI, May 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by its wholly-owned subsidiary T-mab has officially obtaine...
2025-05-30 22:00
3013
Bruno Marc Redefines Summer Dressing with the Flex Oxford Collection
Versatile by Nature, Crafted for the Modern Man.
NEW YORK, May 30, 2025 /PRNewswire/ -- This summer, Bruno Marc introduces the
Flex Oxford Collection
2025-05-30 21:49
4266
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I&I Conditions and U.S. FDA Clearance of IND Application for BBT001
* Preclinical data with BBT002 demonstrate its best-in-disease potential for improved efficacy and dosing convenience across respiratory, dermatology, and gastroenterology indications * Interim safety and pharmacokinetic data from BBT002-01 study anticipated in Q1 2026 * The clearance of BB...
2025-05-30 21:30
4479
National treasure returned home after 79 years of drifting -- under China-U.S. joint escort
BEIJING, May 30, 2025 /PRNewswire/ -- A news report by China.org.cn on the homecoming of Chinese cultural relics:   National treasure returned home after 79 years of drifting — under China-U.S. joint escort Ten days ago, a commercial flight from Washington D.C. touched down ...
2025-05-30 19:34
3268
mF International Limited Announces Results of Annual General Meeting
HONG KONG, May 30, 2025 /PRNewswire/ -- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI), aHong Kong-based experienced financial trading solution provider, today announced the results of its annual general meeting of shareholders held inHong Kong on May 30, 2025. At t...
2025-05-30 19:00
4343
China-Europe-America Think Tank Cooperation Forum Athens Dialogue 2025 Held in Athens, Greece
ATHENS, Greece, May 30, 2025 /PRNewswire/ -- On May 27, the "China
-Europe-America Think Tank Cooperation Forum Athens Dialogue 2025" was held in
Athens, over 30 guests invited from China, France, Italy, the United States and
other countries to the Forum.
2025-05-30 18:28
2756
Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results
XIAMEN, China, May 30, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter endedMarch 31, 2025. First Quarter 2025 Financial Highlights: * Total revenue...
2025-05-30 18:00
4876
So-Young Announces Plan to Implement ADS Ratio Change
BEIJING, May 30, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that the Company plans to change the ratio of the Americ...
2025-05-30 17:00
4797
Elegoo Expands CSR Programs for Social Inclusion, Marking 10 Years of Empowering Creators
SHENZHEN, China, May 30, 2025 /PRNewswire/ -- Elegoo
2025-05-30 15:26
2873
GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal
YONGIN, South Korea, May 30, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase (idursulfase beta), its investigational drug for Hunter Syndrome (MPS II), have been published in Genetics in Medicine, an SCIE-in...
2025-05-30 15:02
2992
Gaming Reimagined: Infinix GT VERSE Merges Power, Play, and Portability in One Seamless Ecosystem
HONG KONG, May 30, 2025 /PRNewswire/ -- As the global gaming population
surpasses 3 billion
2025-05-30 15:00
4117
Milvus Hits 35,000 GitHub Stars as AI Developers Embrace Open-Source Vector Database
Most Popular Vector Database on GitHub Powers Thousands of AI Applications
Worldwide
REDWOOD CITY, Calif., May 30, 2025 /PRNewswire/ -- Zilliz
2025-05-30 14:58
3209
X-Origin AI Introduces Yonbo: The Next-Gen AI Companion Robot Designed for Families
X-Origin AI Launches Its First AI Companion Robot Yonbo on Kickstarter—Meet Your Most Understanding Digital Life Partner for Lifelong Companionship. LOS ANGELES, May 29, 2025 /PRNewswire/ -- X-ORIGIN-AI specializes in the R&D of consumer-grade AI robotics, breaking the constraints of AI as a mere...
2025-05-30 14:31
3948
Bridal Disrupted: How Azazie Is Transforming the UK Wedding Scene, One Pop-Up at a Time
LOS ANGELES, May 30, 2025 /PRNewswire/ -- Azazie
2025-05-30 13:14
3896
Concord Healthcare Announces Official Release of the Proton Therapy Large Model
BEIJING, May 29, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the st...
2025-05-30 04:30
3007
NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA
SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[ 1] SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Austr...
2025-05-30 00:01
4114
HeyGears Launches UltraCraft Reflex RS Turbo with Enhanced Screen Technology
IRVINE, Calif., May 29, 2025 /PRNewswire/ -- The UltraCraft Reflex RS Turbo provides a turbo-charged upgrade to the best-selling Reflex RS, delivering a longer lifespan screen and high precision whilst maintaining a fast printing speed. Exclusive launch offers are now available at HeyGears' onlin...
2025-05-30 00:00
4215
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11
Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00
The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
2026-11-13 13:00
132653
Royal Bank of Canada announces agreement to acquire Yarra Capital Management
2026-11-09 21:00
10284
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
2026-11-09 23:00
9528
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
2026-11-10 22:17
7991
